{"title":"Fertility treatment in women over 50: clinical and ethical considerations","authors":"Sharon Tay, Peter Kerecsenyi, Raj Mathur","doi":"10.1016/j.ogrm.2024.10.004","DOIUrl":null,"url":null,"abstract":"<div><div>As more women prioritize education, career growth, and personal milestones, family planning is increasingly postponed until later in life. Contributing factors such as advanced education, career ambitions, highly effective contraceptive methods, and finding life partners at later stages have led to a growing interest in fertility treatments for women over 50. However, pursuing pregnancy at this age comes with significant clinical and ethical challenges. Women over 50 face elevated risks of aneuploidy, miscarriage, pre-eclampsia, gestational diabetes, and preterm delivery. These complications necessitate rigorous pre-treatment evaluations, enhanced monitoring protocols, and comprehensive care throughout pregnancy. Additionally, ethical concerns arise regarding the welfare of both mother and child, as well as the societal implications of offering fertility treatments to this demographic. This spotlight article explores the clinical risks, ethical considerations, and practical approaches to managing fertility treatment in women over 50.</div></div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":"35 1","pages":"Pages 21-23"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics, Gynaecology and Reproductive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S175172142400157X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
As more women prioritize education, career growth, and personal milestones, family planning is increasingly postponed until later in life. Contributing factors such as advanced education, career ambitions, highly effective contraceptive methods, and finding life partners at later stages have led to a growing interest in fertility treatments for women over 50. However, pursuing pregnancy at this age comes with significant clinical and ethical challenges. Women over 50 face elevated risks of aneuploidy, miscarriage, pre-eclampsia, gestational diabetes, and preterm delivery. These complications necessitate rigorous pre-treatment evaluations, enhanced monitoring protocols, and comprehensive care throughout pregnancy. Additionally, ethical concerns arise regarding the welfare of both mother and child, as well as the societal implications of offering fertility treatments to this demographic. This spotlight article explores the clinical risks, ethical considerations, and practical approaches to managing fertility treatment in women over 50.
期刊介绍:
Obstetrics, Gynaecology and Reproductive Medicine is an authoritative and comprehensive resource that provides all obstetricians, gynaecologists and specialists in reproductive medicine with up-to-date reviews on all aspects of obstetrics and gynaecology. Over a 3-year cycle of 36 issues, the emphasis of the journal is on the clear and concise presentation of information of direct clinical relevance to specialists in the field and candidates studying for MRCOG Part II. Each issue contains review articles on obstetric and gynaecological topics. The journal is invaluable for obstetricians, gynaecologists and reproductive medicine specialists, in their role as trainers of MRCOG candidates and in keeping up to date across the broad span of the subject area.